Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Apr 9:12:1376377.
doi: 10.3389/fpubh.2024.1376377. eCollection 2024.

About cancer screenings and saving lives: measuring the effects of cancer screening programs through meta-analyses-A comment to the meta-analysis "Estimated Lifetime Gained With Cancer Screening Tests" by Bretthauer et al. (2023)

Fabrizio Stracci  1 , Domenico Martinelli  2 , Francesca Maria Anedda  3   4 , Marta Caminiti  5 , William Mantovani  6 , Valentina Pettinicchio  7 , Alessandra Sinopoli  8 , Francesco Vitale  9 , Roberta Siliquini  10 , Walter Mazzucco  9
Affiliations
Comment

About cancer screenings and saving lives: measuring the effects of cancer screening programs through meta-analyses-A comment to the meta-analysis "Estimated Lifetime Gained With Cancer Screening Tests" by Bretthauer et al. (2023)

Fabrizio Stracci et al. Front Public Health. .
No abstract available

Keywords: all-cause mortality; cancer; cancer-specific mortality; follow-up time; lifetime gained; screening efficacy; screening programs; secondary prevention.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

References

    1. Bretthauer M, Wieszczy P, Løberg M, Kaminski MF, Werner TF, Helsingen LM, et al. . Estimated lifetime gained with cancer screening tests: a meta-analysis of randomized clinical trials. J Am Med Assoc Intern Med. (2023) 183:1196–203. 10.1001/jamainternmed.2023.3798 - DOI - PMC - PubMed
    1. Welch HG, Dey T. Testing whether cancer screening saves lives: implications for randomized clinical trials of multicancer screening. J Am Med Assoc Intern Med. (2023) 183:1255–8. 10.1001/jamainternmed.2023.3781 - DOI - PubMed
    1. Black WC, Haggstrom DA, Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst. (2002) 94:167–73. 10.1093/jnci/94.3.167 - DOI - PubMed
    1. Sasieni PD, Wald NJ. Should a reduction in all-cause mortality be the goal when assessing preventive medical therapies? Circulation. (2017) 135:1985–7. 10.1161/CIRCULATIONAHA.116.023359 - DOI - PubMed
    1. Penston J. Should we use total mortality rather than cancer specific mortality to judge cancer screening programmes? Yes. Br Med J. (2011) 343:d6395. 10.1136/bmj.d6395 - DOI - PubMed

LinkOut - more resources